pioglitazone

Generic: pioglitazone

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pioglitazone
Generic Name pioglitazone
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pioglitazone hydrochloride 30 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-6873
Product ID 50090-6873_eaf58d24-cc64-4f48-9c2f-73be817132fd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202467
Listing Expiration 2026-12-31
Marketing Start 2022-08-18

Pharmacologic Class

Classes
peroxisome proliferator receptor alpha agonist [epc] peroxisome proliferator receptor gamma agonist [epc] peroxisome proliferator-activated receptor alpha agonists [moa] peroxisome proliferator-activated receptor gamma agonists [moa] thiazolidinedione [epc] thiazolidinediones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500906873
Hyphenated Format 50090-6873

Supplemental Identifiers

RxCUI
312440
UNII
JQT35NPK6C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pioglitazone (source: ndc)
Generic Name pioglitazone (source: ndc)
Application Number ANDA202467 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (50090-6873-0)
  • 90 TABLET in 1 BOTTLE (50090-6873-1)
source: ndc

Packages (2)

Ingredients (1)

pioglitazone hydrochloride (30 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "eaf58d24-cc64-4f48-9c2f-73be817132fd", "openfda": {"unii": ["JQT35NPK6C"], "rxcui": ["312440"], "spl_set_id": ["4b5506c4-8cc2-44fb-ba2b-0e29fb73943d"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-6873-0)", "package_ndc": "50090-6873-0", "marketing_start_date": "20231204"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-6873-1)", "package_ndc": "50090-6873-1", "marketing_start_date": "20231204"}], "brand_name": "Pioglitazone", "product_id": "50090-6873_eaf58d24-cc64-4f48-9c2f-73be817132fd", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "50090-6873", "generic_name": "Pioglitazone", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pioglitazone", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA202467", "marketing_category": "ANDA", "marketing_start_date": "20220818", "listing_expiration_date": "20261231"}